This site uses cookies, click here for information on the cookies used. Click the "agree" button to accept cookies from this site.

2 3 4 6

RNS News



Company News

16/04/2014: Atlas completes development of ioTM

16/06/2014: Bespak and SteadyMed Therapeutics Enter Into Development Agreement

Our Vision

Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak's rich drug delivery device heritage over the last 50 years and Aesica's decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers' drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities

Our Businesses

bespakBespak serves pharmaceutical companies with inhaler and autoinjector technologies and manufacturing services.

Bespak overview >

AesicaAesica serves pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation and manufacturing services.

Aesica overview >

Interim Results 2014

Quick Links

Share price

price 835.00GBp
change +2.00

For more share price information click here
Tools